Showing results (661-670 of 1,126) with videos related to

Sort By:
Pageof 113
Brain & Development|July 30, 2019
A 16q22.2-q23.1 deletion identified in a male infant with West syndromeTatsuo Mori, Aya Goji, Yoshihiro Toda, et al.
Archives of Virology|May 8, 1998
Construction of a recombinant feline herpesvirus type 1 expressing Gag precursor protein of feline immunodeficiency virusE Sato, N Yokoyama, K Maeda, et al.
The Journal of General Virology|August 1, 1993
The AP-1 binding site in the feline immunodeficiency virus long terminal repeat is not required for virus replication in feline T lymphocytesT Miyazawa, M Kohmoto, Y Kawaguchi, et al.
International Journal of Molecular Medicine|January 20, 2000
Expression of cell cycle regulators and growth factor/receptor systems in gastric carcinoma in young adults: association with Helicobacter pylori infectionK Haruma, M Ito, K Kohmoto, et al.
BMC Ophthalmology|December 21, 2017
A case of proliferative diabetic retinopathy in which scintillating particles appeared in the intravitreal cavity after laser photocoagulationRyohsuke Kohmoto, Takatoshi Kobayashi, Takaki Sato, et al.
Circulation Research|August 1, 1994
Nitric oxide-mediated effects of interleukin-6 on [Ca2+]i and cell contraction in cultured chick ventricular myocytesK Kinugawa, T Takahashi, O Kohmoto, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|December 1, 1996
[Experience with surgery for synchronous double cancer of rectum and lung detected after long-term follow-up for pneumoconiosis]K Tsuji, K Hori, S Kimura, et al.
Aorta (Stamford, Conn.)|April 21, 2018
Coronary Events in Patients Presenting for Repair of Acute Type A Aortic DissectionPaul C Tang, Shahab A Akhter, Satoru Osaki, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 14, 2012
Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapyKenji Inoue, Takayuki Fujimoto, Risako Higa, et al.
The Journal of Physical Chemistry. B|August 6, 2014
Simple and efficient chiral dopants to induce blue phases and their optical purity effects on the physical properties of blue phasesKeiki Kishikawa, Takaaki Sugiyama, Tomohiro Watanabe, et al.
Pageof 113